Advanced Enzyme Technologies Limited — Updates, 31-01-2026: Press Release

Advanced Enzymes' Q3 PAT rose 11% to ₹43.2 Cr, with revenue up 2% to ₹171.9 Cr, despite an 11% EBITDA dip. Animal Nutrition surged 22%, and Bio-Processing grew 13%. The company is expanding B2C with its Wellfa brand and pursuing strategic inorganic growth.